The Inflation Reduction Act (IRA) represents a landmark policy change in the United States. Shifting financial responsibilities and benefit structures will change product strategies, risk-sharing models, and behaviors.
In this webinar we will examine potential direct and indirect impacts to stakeholders including pharmaceutical and biotech manufacturers, payers, physicians, and patients.
This webinar will feature Lumanity’s subject matter experts regarding benefits, product pricing, and access. We will make recommendations to help manufacturers improve decisions as the IRA is implemented.
Webinar – Thursday, February 9, 2023
10:00-11:00am EDT / 15:00-16:00pm GMT
Nancy McGee, JD, MPH, DrPH
Senior Vice President, Health Policy and Public Payers, Lumanity
Tom Murtagh, MBA
Managing Director and Founder Clarion, a Lumanity Business
Amber Gilbert, MBA
Global President, Market Access, Lumanity
Ron Akehurst, BSc, DSc, MFPH
Executive Chair, HEOR, Lumanity